IARC News

Launch of IARC Handbooks of Cancer Prevention website

28/08/2014 The IARC Monographs Programme is pleased to announce the launch of the IARC Handbooks of Cancer Prevention website. The IARC Handbooks of Cancer Prevention provide evaluations of various approaches to primary and secondary cancer prevention. Previous volumes have evaluated the cancer-preventive activity of chemopreventive agents, the effectiveness of screening, and the effectiveness of tobacco control. The new website provides a comprehensive overview of the IARC Handbooks of Cancer Prevention series, with free access to PDFs of published volumes and lists of evaluations for all agents and activities evaluated so far, as well as updated Working Procedures and Guidelines for Observers for future volumes, and information about upcoming meetings. Visit the Handbooks website

Ban on widely used painkiller significantly reduced incidence of renal pelvis cancer

28/08/2014 A new scientific study, conducted jointly by the International Agency for Research on Cancer (IARC) and the New South Wales Cancer Council, evaluates for the first time the long-term impact of the phenacetin ban on upper urinary tract cancer rates. Published today in the Australian and New Zealand Journal of Public Health, the study shows a significant reduction in renal pelvis cancer incidence rates in Australia after phenacetin was banned in 1979, especially among women. Phenacetin, a widely used analgesic, was banned in most countries from the late 1960s because it causes renal diseases and cancers of the upper urinary tract.

S. Antoni, I. Soerjomataram, S. Moore, J. Ferlay, F. Sitas, D. P. Smith, D. Forman
The ban on phenacetin is associated with changes in the incidence trends of upper urinary tract cancers in Australia.
Australian and New Zealand Journal of Public Health, DOI: 10.1111/1753-6405.12252. Published online 28 August 2014
Read more

New report shows that HPV vaccine trials can be significantly shortened

25/08/2014 A new report from a Working Group convened by the International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, and the United States National Cancer Institute (NCI) shows how the evaluation and licensing of prophylactic human papillomavirus (HPV) vaccines could be significantly accelerated. IARC Press Release 226, IARC Working Group Report 7

Publications

Planning and Developing Population-Based Cancer Registration in Low- and Middle-Income Settings

26/05/2014 Planning and Developing Population-Based Cancer Registration in Low- and Middle-Income Settings

Authors: F. Bray, A. Znaor, P. Cueva, A. Korir, R. Swaminathan, A. Ullrich, S.A. Wang, and D.M. Parkin

This guidance document provides an overview of the key concepts in cancer registration, covering the steps involved in planning a registry, the sources of information a registry will need to access, methods for ensuring data quality, and how registry results should be reported. It will be of value to those who are seeking to establish a registry or are in the early stages of developing a registry. It covers the major components that need to be thought about when setting up a registry and ensuring that it provides the necessary information for its main stakeholders -especially those involved in cancer control planning.
Download now